Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:58 UTC |
---|
HMDB ID | HMDB0015376 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Trimeprazine |
---|
Description | Alimemazine, also known as trimeprazine or repeltin, belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. Alimemazine is a drug which is used to prevent and relieve allergic conditions which cause pruritus (itching) and urticaria (some allergic skin reactions). In humans, alimemazine is involved in the alimemazine h1-antihistamine action pathway. Alimemazine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review very few articles have been published on Alimemazine. |
---|
Structure | CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=CC=C12 InChI=1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3 |
---|
Synonyms | Value | Source |
---|
Trimeprazine | Kegg | Repeltin | Kegg | Methylpromazine | Kegg | Alimemazine | KEGG | Trimeperazine | HMDB | Nedeltran | MeSH, HMDB | Evans brand OF alimemazine tartrate | MeSH, HMDB | Panectyl | MeSH, HMDB | Pierre fabre brand OF alimemazine | MeSH, HMDB | Rhône poulenc rorer brand OF alimemazine tartrate | MeSH, HMDB | Rhône-poulenc rorer brand OF alimemazine tartrate | MeSH, HMDB | Spansule | MeSH, HMDB | Théralène | MeSH, HMDB | Isobutrazine | MeSH, HMDB | Variargil | MeSH, HMDB | Alimemazine italfarmaco brand | MeSH, HMDB | Allergan brand OF alimemazine tartrate | MeSH, HMDB | italfarmaco Brand OF alimemazine | MeSH, HMDB | Vallergan | MeSH, HMDB |
| Show more...
---|
Chemical Formula | C18H22N2S |
---|
Average Molecular Weight | 298.446 |
---|
Monoisotopic Molecular Weight | 298.150369404 |
---|
IUPAC Name | dimethyl[2-methyl-3-(10H-phenothiazin-10-yl)propyl]amine |
---|
Traditional Name | trimeprazine |
---|
CAS Registry Number | 84-96-8 |
---|
SMILES | CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3 |
---|
InChI Key | ZZHLYYDVIOPZBE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzothiazines |
---|
Sub Class | Phenothiazines |
---|
Direct Parent | Phenothiazines |
---|
Alternative Parents | |
---|
Substituents | - Phenothiazine
- Alkyldiarylamine
- Diarylthioether
- Aryl thioether
- Tertiary aliphatic/aromatic amine
- Para-thiazine
- Benzenoid
- Tertiary amine
- Tertiary aliphatic amine
- Thioether
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 68 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0084 g/L | Not Available | LogP | 4.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Trimeprazine EI-B (Non-derivatized) | splash10-0a4i-9010000000-3652afb69d877d9e3ef5 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Trimeprazine EI-B (Non-derivatized) | splash10-0a4i-9240000000-3d6ddecfeef1ce4ea2a2 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Trimeprazine CI-B (Non-derivatized) | splash10-0002-1192000000-93fd466d9dd2ccc3c679 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Trimeprazine EI-B (Non-derivatized) | splash10-0a4i-9010000000-3652afb69d877d9e3ef5 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Trimeprazine EI-B (Non-derivatized) | splash10-0a4i-9240000000-3d6ddecfeef1ce4ea2a2 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Trimeprazine CI-B (Non-derivatized) | splash10-0002-1192000000-93fd466d9dd2ccc3c679 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Trimeprazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-08fr-7190000000-0f8a5eefc8992f88c42e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Trimeprazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Trimeprazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 10V, Positive-QTOF | splash10-0f6t-0390000000-d19c7e0d929f71a4ad36 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 20V, Positive-QTOF | splash10-0udi-3790000000-934bfb5b005b12a5e73d | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 40V, Positive-QTOF | splash10-0pc3-9310000000-63ebd221a8008ee5907e | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 10V, Negative-QTOF | splash10-0002-0190000000-2baf4399efd26ce01a1a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 20V, Negative-QTOF | splash10-000b-0950000000-4297ad548b801681761c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 40V, Negative-QTOF | splash10-0002-2900000000-a79d6af3311c241ede5f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 10V, Positive-QTOF | splash10-0002-0090000000-6922163e7f4e54a0d111 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 20V, Positive-QTOF | splash10-0pba-7390000000-e48c69f05dd0b61fb4a3 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 40V, Positive-QTOF | splash10-0a4i-9330000000-2a742cf0712cb4007fb6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 10V, Negative-QTOF | splash10-0002-0090000000-974be3fbdd37312b3898 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 20V, Negative-QTOF | splash10-0002-0590000000-923a0af0890995a5d8a8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimeprazine 40V, Negative-QTOF | splash10-03ds-0970000000-966b5b52892fcd5adc27 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01246 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01246 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01246 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5373 |
---|
KEGG Compound ID | C07172 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Alimemazine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | Not Available |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | Not Available |
---|